Four-Pronged attack on Tough-to-Treat blood cancer
NCT ID NCT05497804
Summary
This study is testing a combination of four chemotherapy drugs to treat a more aggressive form of multiple myeloma, a blood cancer. The main goal is to see if this treatment can make the cancer undetectable in blood tests and keep it that way for at least a year. It is for newly diagnosed patients with specific high-risk features and involves a long treatment and follow-up plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.